AIRA Matrix, a leading innovator in AI-driven QC solutions, and Gestalt, an industry leader in IMS and digital pathology, have formed a strategic partnership to bring AIRA Matrix’s advanced AI solution, AIRAQC, to Gestalt’s PathFlow. This collaboration marks a significant step toward enhancing diagnostic precision and efficiency in laboratories worldwide.
AIRAQC, powered by cutting-edge artificial intelligence, streamlines quality control processes, enabling faster and more accurate analysis in pathology workflows. By integrating AIRAQC with Gestalt’s workflows, pathologists will gain access to a seamless, AI-enhanced experience designed to optimize diagnostic decision-making.
Also Read: Subtle Medical Drives GenAI Innovation in Radiology
“We’re thrilled to partner with Gestalt to expand the reach of AIRAQC and deliver transformative AI capabilities to pathology labs,” said Marco Comianos, Head of Commercial Operations – US., AIRA Matrix. “This collaboration is a testament to our shared commitment to advancing pathology through innovation.”
“The partnership between AIRA Matrix and Gestalt represents a continued effort to drive progress in pathology by leveraging technology to meet evolving healthcare needs. Together, our companies aim to empower laboratories with state-of-the-art tools that improve diagnostic accuracy, quality and meaningful metrics from the start of the diagnostic process” says Lisa-Jean Clifford, Gestalt COO & Chief Strategy Officer.
Source: PRNewswire
